Management Team

Michael Pisano, Ph.D

Chief Executive Officer, NextGen Sciences Inc

Dr. Pisano's formal training is in protein biochemistry and his expertise includes protein separations and characterization, proteomics, and protein mass spectrometry. Dr. Pisano’s career includes more than 11 years in the pharmaceutical industry. He has managed laboratory research groups within the pharmaceutical industry in the areas of protein sciences since 1996. Positions he has held in the pharmaceutical industry include Group Leader, Proteomics and Protein Production, Dept. of Biotechnology, Rhone-Poulenc Rorer Pharmaceuticals; Head, Protein Sciences, Dept. of Biotechnology Aventis Pharmaceuticals; Vice-President Proteomic R&D, Genomic Solutions, Inc. In addition, Dr. Pisano was co-founder and President of Proteomic Research Services, Inc.(PRS), a contract research laboratory founded in 2001 and based in Ann Arbor, Michigan. In 2006 PRS was acquired by NextGen Group and Dr. Pisano was appointed Chief Scientific Officer and President of NextGen Sciences Inc.

Ian Kelly

VP Technology

Mr Kelly joined the company in January 2001 and has been responsible for the development of software and automation for a variety of different products including the ProteinArray Workstation, a2DEoptimizer and more recently the ExpressionFactory and ExpressionWorkstation protein expression platforms. He now heads the team implementing a Laboratory Information Management System and developing automated sample preparation capabilities for the company's biomarker testing division. Mr Kelly has extensive product development experience in a variety of different industries, including avionics, petrochemical and transportation. Prior to joining NextGen Sciences, Mr Kelly worked at Terrington Systems as Principal Engineer where he led a multi-disciplinary team developing an innovative high-performance aircraft data recorder and data-warehousing system for a variety of different customers including the UK Ministry of Defence, BAE SYSTEMS and NASA. Previously he worked at the engineering consultancy Oscar Faber as Senior Consultant, managing the design and development of transportation information and control systems.

Richard Jones, Ph.D

Head of Mass Spectrometry

Dr. Jones has extensive experience in protein mass spectrometry. After graduating from Professor Simon J. Gaskell's group at UMIST, he was a post-doctoral scientist at Aventis Pharmaceuticals and then moved on to become a Senior Scientist at Genomic Solutions and Proteomic Research Services. Dr Jones then worked at the FDA for 5 years as a principal investigator and has been at NextGen since March 2007. Dr. Jones has expertise utilizing many mass spectrometry platforms for high sensitivity protein and peptide analysis encompassing identification, characterization and quantitation. At NextGen he has established robust, sensitive platforms for biomarker discovery, assay development and monitoring using mass spectrometry.

Board of directors